
Synairgen, a Southampton-based drug development company, has started testing its inhaler in COVID-19 patients, and claims it can fight the killer bug at the first sign of symptoms
Music
Trailers
DailyVideos
India
Pakistan
Afghanistan
Bangladesh
Srilanka
Nepal
Thailand
Iraq
Iran
Russia
Brazil
StockMarket
Business
CryptoCurrency
Technology
Startup
Trending Videos
Coupons
Football
Search
Download App in Playstore
Download App
Best Collections
Synairgen, a Southampton-based drug development company, has started testing its inhaler in COVID-19 patients, and claims it can fight the killer bug at the first sign of symptoms